ArticleACS medicinal chemistry letters2026

Targeted Degradation of CDK2: A New Strategy for Overcoming Cyclin E‑Driven Cancers.

Anna C Renner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.